C21 Investments (TSE:CXXI) has released an update.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
C21 Investments reported a strong second quarter, with revenue growing 14% to $7.5 million, driven by the successful launch of their new South Reno dispensary. The company achieved a notable increase in gross margin to 43.5%, up from 31% in the previous quarter, and improved adjusted EBITDA to $1.3 million from $0.3 million in Q1. Despite a net loss of $0.8 million primarily due to tax expenses, C21’s strategic expansion efforts are demonstrating promising growth and operational efficiencies.
For further insights into TSE:CXXI stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue